244 related articles for article (PubMed ID: 33641015)
1. Macrophages in dermatology: pathogenic roles and targeted therapeutics.
Kuraitis D; Rosenthal N; Boh E; McBurney E
Arch Dermatol Res; 2022 Mar; 314(2):133-140. PubMed ID: 33641015
[TBL] [Abstract][Full Text] [Related]
2. Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo.
Wu X; Schulte BC; Zhou Y; Haribhai D; Mackinnon AC; Plaza JA; Williams CB; Hwang ST
J Invest Dermatol; 2014 Nov; 134(11):2814-2822. PubMed ID: 24780929
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of psoriasis and cutaneous T-cell lymphoma.
Scott J; Lai C; Coltart G; Bates A; Bennett L; Sommerlad M; Foria V; Healy E
Clin Exp Dermatol; 2023 Sep; 48(10):1155-1159. PubMed ID: 37379526
[TBL] [Abstract][Full Text] [Related]
4. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
5. Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: Differences in clinical presentation and disparities in cutaneous disorders in skin of color.
McKenzie S; Brown-Korsah JB; Syder NC; Omar D; Taylor SC; Elbuluk N
J Am Acad Dermatol; 2022 Dec; 87(6):1261-1270. PubMed ID: 35817332
[TBL] [Abstract][Full Text] [Related]
6. A 62-year-old man presenting with widespread nodulo-ulcerative cutaneous lesions.
Farrar CW; Jack AS; Lyon C; Cowan RA; Griffiths CE; Ashworth J
Clin Exp Dermatol; 2001 Jan; 26(1):115-9. PubMed ID: 11260199
[No Abstract] [Full Text] [Related]
7. If small plaque (digitate) parapsoriasis is a cutaneous T-cell lymphoma, even an 'abortive' one, it must be mycosis fungoides!
Ackerman AB
Arch Dermatol; 1996 May; 132(5):562-6. PubMed ID: 8624154
[No Abstract] [Full Text] [Related]
8. The use of immunohistologic analysis in differentiating cutaneous T-cell lymphoma from psoriasis and dermatitis.
Verga M; Braverman IM
Arch Dermatol; 1991 Oct; 127(10):1503-10. PubMed ID: 1929457
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease. Two indications for photopheresis in dermatology.
Girardi M; Heald PW
Dermatol Clin; 2000 Jul; 18(3):417-23, viii. PubMed ID: 10943537
[TBL] [Abstract][Full Text] [Related]
10. Progression of undiagnosed cutaneous T-cell lymphoma during efalizumab therapy.
Hernandez C; Worobec SM; Gaitonde SS; Kiripolsky ML; Aquino K
Arch Dermatol; 2009 Jan; 145(1):92-4. PubMed ID: 19153358
[No Abstract] [Full Text] [Related]
11. Secukinumab for treatment of psoriasis: does secukinumab precipitate or promote the presentation of cutaneous T-cell lymphoma?
Yoo J; Shah F; Velangi S; Stewart G; Scarisbrick JS
Clin Exp Dermatol; 2019 Jun; 44(4):414-417. PubMed ID: 30284290
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine.
Corazza M; Zampino MR; Montanari A; Altieri E; Virgili A
Dermatology; 2003; 206(4):330-3. PubMed ID: 12771475
[TBL] [Abstract][Full Text] [Related]
13. De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma.
Wolfe JT; Singh A; Lessin SR; Jaworsky C; Rook AH
J Am Acad Dermatol; 1995 May; 32(5 Pt 2):887-93. PubMed ID: 7722051
[TBL] [Abstract][Full Text] [Related]
14. Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
Quéreux G; Renaut JJ; Peuvrel L; Knol AC; Brocard A; Dréno B
Acta Derm Venereol; 2010 Nov; 90(6):616-20. PubMed ID: 21057746
[TBL] [Abstract][Full Text] [Related]
15. [Cutaneous lymphomas. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V].
Dummer R
Hautarzt; 1998 Oct; 48 Suppl 1():S49-55. PubMed ID: 9866049
[No Abstract] [Full Text] [Related]
16. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
17. Pathology of cutaneous T-cell lymphoma.
Burg G; Dummer R; Dommann S; Nestle F; Nickoloff B
Hematol Oncol Clin North Am; 1995 Oct; 9(5):961-95. PubMed ID: 8522491
[TBL] [Abstract][Full Text] [Related]
18. Epidermal stem cells - role in normal, wounded and pathological psoriatic and cancer skin.
Kamstrup M; Faurschou A; Gniadecki R; Wulf HC
Curr Stem Cell Res Ther; 2008 May; 3(2):146-50. PubMed ID: 18473880
[TBL] [Abstract][Full Text] [Related]
19. Functions and uses of immunohistochemical stains in cutaneous infiltrates of hematopoietic origin: a review for the practicing dermatologist.
Chisholm C; Cockerell CJ
J Cutan Med Surg; 2011; 15(2):65-83. PubMed ID: 21477554
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous natural killer/T-cell lymphoma.
Radonich MA; Lazova R; Bolognia J
J Am Acad Dermatol; 2002 Mar; 46(3):451-6. PubMed ID: 11862188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
